From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.
You can find the latest information on our research, clinical and educational programs through this listing of current press releases.
An international team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., the Norman and Sadie Lee Foundation Endowed Professor in Pediatrics and founding chair of the Department of Systems Biology, found a connection between drug-resistance in acute lymphoblastic leukemia (ALL) and increased sugar uptake in the ALL cells, according to the paper titled, “Metabolic gatekeeper function of B-lymphoid transcription factors,” published today in Nature.
World-renowned diabetes researcher Arthur D. Riggs, Ph.D., director of the Diabetes & Metabolism Research Institute of City of Hope and director emeritus of Beckman Research Institute of City of Hope, has been named the Samuel Rahbar Chair in Diabetes & Drug Discovery, which honors the life and legacy of the late renowned scientist.
A significant philanthropic gift from the Campbell family of Las Vegas, NV, will establish a new endowed chair to honor City of Hope’s former Chief Medical Officer Alexandra M. Levine, M.D., M.A.C.P.
City of Hope, a world-renowned independent research and cancer and diabetes treatment center, and San Antonio Regional Hospital announced today an affiliation agreement that will significantly expand access to leading-edge, high-quality cancer care, research and services in the Inland Empire.
Debbie C. Thurmond, Ph.D., a professor in City of Hope’s Diabetes and Metabolism Research Institute and founding chair of the Department of Molecular and Cellular Endocrinology, has been named the Ruth B. & Robert K. Lanman Chair in Gene Regulation and Drug Discovery Research.
With a shared vision of working to eliminate health disparities in the African American community, Anthem, Inc., the National Urban League, City of Hope and Pfizer, Inc., announce the launch of Take Action for Health, a free interactive website aimed at reducing some of the greatest health risks facing the African American community today: breast cancer, heart disease and emotional well-being.
A cure for Type 1 diabetes (T1D) in six years is the new goal of City of Hope’s Diabetes and Metabolism Research Institute. Through the generosity of the Wanek family and gifts from anonymous donors, the institution will be able to devote more than $50 million over the next six years to an innovative research effort that seeks to find a cure for T1D.
City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.
In an analysis led by City of Hope’s Stacy Gray, M.D., clinical professor of clinical cancer genetics in the Department of Population Sciences, researchers found that elevated cancer risk revealed by personal genomic testing doesn’t change behavior.
For the 45th year, City of Hope will be participating in the 128th annual Tournament of Roses Parade celebrating the past, present and future successes of City of Hope’s physicians, researchers, scientists, nurses and survivors.